Market Overview

Benzinga's Top Initiations

Related ALB
UPDATE: Deutsche Bank Reiterates On Albemarle On Fair Valuation
Earnings Scheduled For July 30, 2014
Related INSY
Insys Therapeutics Shares Fall Following Publication Of Cleveland Research Report
2 Biotech Stocks That Beat The Market Last Week

Analysts at Topeka Capital initiated coverage on shares of Albemarle (NYSE: ALB) with a “hold” rating. The target price for Albemarle is set to $67. Albemarle's shares closed at $61.88 yesterday.

Oppenheimer initiated coverage on shares of Insys Therapeutics (NASDAQ: INSY) with an “outperform” rating. The target price for Insys Therapeutics is set to $23. Insys Therapeutics's stock closed at $16.05 yesterday.

SunTrust Robinson Humphrey initiated coverage on shares of Goodrich Petroleum (NYSE: GDP) with a “buy” rating. The target price for Goodrich Petroleum is set to $25. Goodrich Petroleum's shares closed at $17.97 yesterday.

Analysts at Credit Suisse initiated coverage on shares of Sunesis Pharmaceuticals (NASDAQ: SNSS) with a “buy” rating. The target price for Sunesis Pharmaceuticals is set to $25. Sunesis's shares closed at $5.40 yesterday.

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Most Popular

Related Articles (ALB + GDP)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional